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OBJECTIVE: Intravenous infusion of crystalloid solutions is a cornerstone of the treatment of hemorrhagic shock.
However, crystalloid solutions can have variable metabolic acid-base effects, perpetuating or even aggravating
shock-induced metabolic acidosis. The aim of this study was to compare, in a controlled volume–driven porcine
model of hemorrhagic shock, the effects of three different crystalloid solutions on the hemodynamics and acid-base
balance.
METHODS: Controlled hemorrhagic shock (40% of the total blood volume was removed) was induced in 18 animals,
which were then treated with normal saline (0.9% NaCl), Lactated Ringer’s Solution or Plasma-Lyte pH 7.4, in a
blinded fashion (n=6 for each group). Using a predefined protocol, the animals received three times the volume of
blood removed.
RESULTS: The three different crystalloid infusions were equally capable of reversing the hemorrhage-induced low
cardiac output and anuria. The Lactated Ringer’s Solution and Plasma-Lyte pH 7.4 infusions resulted in an increased
standard base excess and a decreased serum chloride level, whereas treatment with normal saline resulted in a
decreased standard base excess and an increased serum chloride level. The Plasma-Lyte pH 7.4 infusions did not
change the level of the unmeasured anions.
CONCLUSION: Although the three tested crystalloid solutions were equally able to attenuate the hemodynamic and
tissue perfusion disturbances, only the normal saline induced hyperchloremia and metabolic acidosis.
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INTRODUCTION
Hemorrhagic shock is a well-known cause of metabolic
acidosis, which is associated with a poor prognosis.1
Hypothermia, coagulopathy, and acidosis comprise what
has been termed the ‘‘trauma triad of death.’’2
Intravenous infusion of crystalloid solutions is a corner-
stone of hemorrhagic shock treatment, and it can both
restore the intravascular compartment and maintain cardiac
output and tissue perfusion.3 However, crystalloid solutions
can have variable metabolic acid-base effects, sometimes
perpetuating or aggravating metabolic acidosis.4 Normal
saline is a very frequently used solution,5 but its use has
been associated with the development of hyperchloremic
acidosis.6,7 The use of so-called ‘‘balanced solutions,’’ which
are more similar to human plasma in terms of electrolytes
and acid-base chemistry, may avoid this problem.4 Lactated
Ringer’s (LR) Solution and Plasma-Lyte pH 7.4 are two
balanced solutions that are commonly used in clinical
practice.
To our knowledge, no study has compared the effects of
these three solutions on the quantitative acid-base and
hemodynamic profiles in a hemorrhagic scenario. Therefore,
the aim of this study was to compare, in a controlled,
volume-driven porcine model of hemorrhagic shock, the
effects of three different crystalloid solutions on the
hemodynamics and quantitative acid-base balance.
MATERIALS AND METHODS
Animals
All experiments were carried out in accordance with the
National Institutes of Health (1985) and the American
Physiological Society (1995) principles on the care, manip-
ulation, and protection of laboratory animals, after the
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approval of the Animal Ethics Committee from Hospital
Israelita Albert Einstein, Sa˜o Paulo, Brazil.
Eighteen healthy, male white pigs (30.4¡4.2 kg) were
used in the experiments. The animals were evaluated by a
veterinarian before and during all experiments. Access to
food was suspended 12 hours prior to surgery, but free
access to water was always provided.
Surgical procedures
Animals were anesthetized using the following protocol:
the pigs were pre-medicated with ketamine (10 mg/kg,
i.m.) and midazolam (0.25 mg/kg, i.m.). Propofol (5 mg/kg
i.v.) was used to induce anesthesia, which was maintained
with a continuous i.v. infusion of fentanyl (2.5 mg/kg/h),
pancuronium (0.4 mg/kg/h) and isoflurane (1.5%).
After induction, the animals were orotracheally intu-
bated (6.5–7.0 tubes) and mechanically ventilated (Origami
Takaoka, K. Takaoka, Brazil) using the volume assist-
control mode with the following parameters: tidal volume,
10 ml/kg body weight; positive ending expiratory pres-
sure (PEEP), 5 cmH2O; and 25–30% of fractional inspira-
tory O2 concentration (FiO2). The goal was to maintain a
normal partial pressure of oxygen (PaO2, 60–100 mmHg)
in an arterial blood sample. The respiratory rate (RR) was
adjusted to obtain a normal carbon dioxide partial
pressure (PaCO2, 35–45 mmHg) in an arterial blood
sample. Thermal blankets were used to keep the core
temperature around 38 C˚.
During all anesthetic and surgical procedures, continuous
electrocardiography monitoring was performed (Dixtal 2021
monitor, Brazil). Arterial and venous lines were placed via left
inguinal (femoral) dissection. The arterial line was connected
to a pressure transducer (Edwards Lifesciences, USA) to
provide continuous arterial pressure measurements (Dixtal
2021 monitor, Brazil). The right jugular vein was also dissected
to allow for pulmonary artery catheterization (7F Swan-Ganz,
Edwards Lifesciences, USA) and continuous cardiac output
measurement (Vigilance, Edwards Lifesciences, USA).
A mini-laparotomy and a cystostomy were performed in
all animals to quantify urinary output.
Experimental protocol
During surgical preparation, 20 ml/kg of normal saline
was administered to all animals. After performing the
sedation, mechanical ventilation, and vascular access,
controlled hemorrhagic shock was induced in the animals.
Based on the calculated ratio of 76 ml blood/kg of body
weight,8 we estimated the total blood volume to guide the
exsanguination process. Forty percent of the total blood
volume was removed via manual blood withdrawal
through the arterial catheter in three equal aliquots, with
a 30-minute interval between withdrawals. The animals
were then randomly allocated to one of the three
resuscitation groups (six animals per group): Normal
Saline (0.9% NaCl, Baxter Viaflex, Brazil), LR solution
(Lactated Ringer’s Solution, Baxter, Viaflex, Brazil), or
Plasma-Lyte pH 7.4 (Baxter Healthcare Corporation, USA)
in a blinded fashion. The composition of the solutions is
described in Table 1. We started the resuscitation with one
of the three crystalloid solutions one hour after the
bleeding was completed. The total volume infused was
three times the total blood volume removed. The total time
to infuse the crystalloid solution was 10–15 min per animal,
and the infusion was performed using a pressurized
system (300 mmHg).
The heart rate, blood pressure, cardiac output and SvO2
were monitored during all phases of the experiment:
baseline, after each blood withdrawal, 30 min after finishing
the bleeding process, immediately after resuscitation and
1 hour after resuscitation. Blood samples were collected
before the first blood withdrawal, 1 hour after the final
blood withdrawal and 1 hour after the resuscitation process.
After the protocol was complete, the animals were eutha-
nized via anesthetic overdose followed by injection of a
20 ml KCl (19.1%) i.v. bolus.
Laboratory samples
Arterial blood samples were collected in heparinized
syringes and analyzed using a blood-gas analyzer (ABL
700, Radiometer, Copenhagen, Denmark). The analyzer
measured samples at 37 C˚. We collected the following data
from the analyzer output: pH, partial pressure of carbon
dioxide, bicarbonate, standard base excess (SBE), and
ionized calcium. The plasma sodium, chloride, lactate,
and potassium levels were measured using ion-selective
electrodes in the blood-gas analyzer. The machine calcu-
lated the bicarbonate concentration using the Henderson–
Hasselbach equation. The SBE was calculated according to
Wooten’s equation,9 the formula least sensitive to PCO2,
because our experiment was prone to large variations in
the PCO2. Additionally, 5 ml of plasma was collected and
stored at -80 C˚. The magnesium (calorimetric method using
Formazan dye and Randox blue xylitol, Vitros System,
Johnson & Johnson, USA), albumin (calorimetric method
using Randox Bromocresol green, dry chemistry, Vitros
System, Johnson & Johnson, USA), and phosphate (calori-
metric method and dry chemistry, Vitros System, Johnson
& Johnson, USA) levels were measured in these plasma
samples.
Conceptual framework for acid-base analysis
To separate the independent components of the acid-base
disturbances, we performed a quantitative physicochemical
analysis using Stewart’s methodology, as modified by Figge
et al. and others.10-12 In this approach, the H+ concentration
and, therefore pH, is determined using three independent
variables: the strong ion difference (SID); the total concen-
tration of weak acids (Atot), which is mainly determined by
the albumin and phosphate levels; and the PCO2.
This method initially involves the calculation of the
apparent strong ion difference (SIDa):
Table 1 - Characteristics of the fluids used for
resuscitation.
Normal
Saline
Lactated Ringer’s
Solution
Plasma-Lyte
pH 7.4
Sodium (mEq/l) 154 130 140
Potassium (mEq/l) 0 4 5
Calcium (mEq/l) 0 3 0
Magnesium (mEq/l) 0 0 3
Chloride (mEq/l) 154 109 98
Lactate (mEq/l) 0 28 0
Gluconate (mEq/l) 0 0 23
Acetate (mEq/l) 0 0 27
Osmolarity (mOsm/l) 308 275 294
pH 5.50 6.75 7.40
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SIDa~ Naz½ z Kz½ z Mg2z z Ca2z {
Cl{½ { lactate{½ 
All concentrations inmEq=lð Þ
Because lactate is an independent determinant of mortal-
ity in critically ill patients following ICU admission,13,14 the
SIDa was ‘‘partitioned’’ into the inorganic ion difference
([Na+] + [K +] + [Mg2+] + [Ca2+] - [Cl2]) and the plasma
lactate level.
Alternatively, the SID can be calculated by taking into
account the role of weak acids (e.g., CO2, albumin, and
phosphate) in the balance of electrical charges in the plasma
water. This method results in the effective strong ion
difference (SIDe). The formula for SIDe, as determined by
Figge et al.,12 is as follows:
SIDe~2:46|10pH{8|PCO2 z Albumin½ |(0:123|pH{ 0:631)
z Phosphate½ |(0:309|pH{ 0:469)
PCO2 is measured in mmHg, albumin is measured in g/L,
and phosphate is measured in mmol/L.
The difference between the SIDa and SIDe should equal 0
(electrical charge neutrality), unless there are unmeasured
charges to explain this ‘‘ion gap.’’ Such charges are
described by the strong ion gap (SIG):11
SIG~ SIDa{ SIDe
A positive SIG represents unmeasured anions (e.g.,
sulfate, keto acids, citrate, pyruvate, acetate, gluconate,
etc.), which must be included to account for the measured
pH.
Statistical analysis
The data were assessed for a normal distribution using
the Kolmogorov-Smirnov goodness-of-fit model and are
presented as the mean and standard deviation. The baseline
mean values were compared using a one-way analysis of
variance (one-way ANOVA), with a post-hoc Tukey’s test.
Hemodynamic, oxygen and laboratory variables were
compared by two-way ANOVA, focusing on the group vs.
time interaction. The significance level was set at p,0.05 for
single comparisons. The commercially available SPSS 10.0
statistical package (Chicago, Illinois, USA) was used to
perform the statistical analysis.
RESULTS
Table 2 shows the baseline characteristics for the animals
in each experimental group. The groups were not different
with respect to any of the studied characteristics, except for
a slightly higher SIG in the Plasma-Lyte pH 7.4 group when
compared to the LR group.
The mean blood volume removed in each group was 955
(¡163) ml in the Normal Saline group, 925 (¡127) ml in the
LR group and 896 (¡105) ml in the Plasma-Lyte pH 7.4
group, with no statistical difference among the three groups
(p= 0.75).
The hemorrhage induced an increase in the heart rate, a
decrease in the cardiac output and a trend towards a
decrease in the blood pressure; these changes were of the
same magnitude in the three groups. The resuscitation
phase took less than 15 min for all animals. The total
volume of fluid infused per animal was 2865 (¡488) ml in
the Normal Saline group, 2774 (¡381) ml in the LR group
and 2681 (¡314) ml in the Plasma-Lyte pH 7.4 group, with
no significant difference among the three groups with a
single p-value reported. The three crystalloid solutions were
equally able to attenuate the hemodynamic alterations
(Table 3). The post-hoc analysis comparing the equilibrium
and baseline time points showed a complete reversion of the
decreased cardiac output (p= 0.25) and a partial reversion of
the increased heart rate (p= 0.02). From the beginning of the
hemorrhage until the beginning of the fluid resuscitation, all
animals were anuric. The urine output after the beginning of
fluid resuscitation was not different among the three
groups: 218 (¡147) ml/h for the normal saline group, 154
(¡75) ml/h for the LR group, and 205 (¡240) ml/h for the
Plasma-Lyte pH 7.4 group (p= 0.753). Oxygen delivery
(DO2) and consumption (VO2) and mixed oxygen saturation
(SvO2) had similar patterns among the three groups. The
decrease in the DO2 and SvO2 were only partially reversed
following fluid infusion in all groups (equilibrium vs.
baseline; p,0.01 for both variables).
The three groups were similar with respect to all
laboratory values recorded after hemorrhage, including
SIG. The infusion of normal saline induced a negative SBE
and a highly significant increase in the plasma chloride
concentration, whereas the infusion of Ringer’s lactate and
Plasma-Lyte pH 7.4 induced a positive SBE and a negative
plasma chloride concentration (Figure 1). The Plasma-Lyte
pH 7.4 infusion did not induce the accumulation of
unmeasured anions, as demonstrated by the SIG values
(Table 4).
DISCUSSION
In this study, we demonstrate, using an experimental
model of hemorrhagic shock, that Plasma-Lyte pH 7.4 and
LR Solution cause an increase in the SBE, while normal
saline lowers the SBE. Applying a quantitative acid-base
approach, we demonstrated that Plasma-Lyte pH 7.4 did not
cause an accumulation of unmeasured anions. Accordingly,
the difference in the SBE was mainly attributable to fluid-
induced variations in the serum chloride level. The three
solutions were equally effective in attenuating the macro-
hemodynamic alterations. While the lactate levels tended to
decrease following the administration of normal saline and
Plasma-Lyte pH 7.4, but not LR solution, this difference was
not statistically significant.
Hyperchloremic acidosis is a well-known phenomenon.15
Furthermore, in clinical practice, the intravenous infusion of
chloride-rich solutions, such as normal saline, is commonly
associated with the development of hyperchloremic acido-
sis.16 This association has been described in several
scenarios, including in normal volunteers,6 but seems to
be increased in patients with inflammation.17 After devel-
opment, hyperchloremic acidosis takes a few days to
resolve.18 However, the consequences of hyperchloremic
acidosis are not well established.19 Some studies report no
impact on clinical outcome,14 while other studies found an
impact.10 Small studies have suggested that large infusions
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of normal saline may be detrimental to renal function.21
Despite the controversy regarding its impact on clinical
outcome, hyperchloremia can have deleterious effects, such
as increase in the tumor necrosis factor (TNF), interleukin
(IL)-6, and IL-10 levels,22 a decrease in urine output,23 and
coagulation disturbances.24,25 However, there is no defini-
tive conclusion as to whether these deleterious effects are
directly related to the hyperchloremia or if they are
mediated by metabolic acidosis and/or acidemia.
The use of balanced solutions has been studied in some
experimental and clinical situations. In experimental sepsis,
Kellum et al.26 demonstrated that animals resuscitated with
Hextend (a colloid based balanced solution) survived 45%
longer and had significantly less metabolic acidosis than
animals treated with normal saline. Furthermore, the
survival time was positively correlated with the changes
in pH and negatively correlated with the increase in serum
chloride after initial resuscitation. Similar results were
found in a massive hemorrhagic model. Rats resuscitated
with normal saline were significantly more acidotic than
rats resuscitated with an equal volume of LR and had
significantly worse survival (50% vs. 100%, respectively).27
In a clinical study of elderly surgical patients,28 the use of
LR solution and Hextend prevented the development of
hyperchloremic metabolic acidosis and resulted in
improved gastric mucosal perfusion when compared with
saline-based solutions.
Few studies have specifically examined the use of Plasma-
Lyte pH 7.4. Results similar to ours have been reported
following its use in patients who underwent general surgery
or kidney transplantation.21 It should be noted, however,
that a quantitative approach was not used in these studies;
therefore, the unmeasured anions could not be precisely
estimated. Based on our results, Plasma-Lyte pH 7.4 and LR
Table 2 - Baseline metabolic characteristics of the groups.
Characteristics
Normal Saline
(n=6)
Lactated Ringer’s Solution
(n=6)
Plasma-Lyte pH 7.4
(n=6) p-value *
pH 7.39¡0.06 7.40¡0.06 7.43¡0.05 0.593
PaCO2 (mmHg) 44¡7 42¡2 39¡5 0.253
Bicarbonate (mEq/l) 26.4¡2.7 25.8¡2.0 25.0¡1.5 0.564
SBE (mEq/l) 2.8¡2.1 1.0¡2.1 1.2¡1.3 0.292
SIDai (mEq/l) 42.3¡2.0 39.5¡3.3 41.5¡0.8 0.134
Sodium (mEq/l) 136.1¡2.4 135.9¡2.6 137.0¡2.8 0.744
Chloride (mEq/l) 102¡4 103¡5 103¡3 0.653
Lactate (mEq/l) 1.7¡1.3 1.5¡0.7 1.2¡0.5 0.684
Albumin (g/dl) 2.4¡0.3 2.2¡0.4 2.4¡0.2 0.581
Hemoglobin (g/dl) 10.6¡0.8 9.7¡0.9 11,0¡1.0 0.068
SIG (mEq/l) 2.3¡1.9 0.8¡1.5 3.6¡1.3 0.030
Data are expressed as the mean ¡ SD.
*p-values were calculated using a one-way ANOVA.
Table 3 - Effects of crystalloid infusion on the hemodynamic and oxygenation parameters.
{{Parameter Group Baseline Hemorrhage Equilibrium{ p-value *
MAP Normal Saline
Lactated Ringer’s Solution
Plasma-Lyte pH 7.4
99.5¡31.0
107.5¡24.2
101.8¡26.6
78.8¡27.9
87.7¡18.1
68.0¡34.0
80.7¡29.0
107.5¡31.8
85.7¡33.2
0.125*
0.124#
HR Normal Saline
Lactated Ringer’s Solution
Plasma-Lyte pH 7.4
114.4¡29.7
143.0¡28.8
141.7¡27.1
207.4¡31.6
208.8¡25.1
204.5¡16.4
159.4¡29.4
168.2¡40.8
181.3¡15.6
,0.0001*
0.075#
CO Normal Saline
Lactated Ringer’s Solution
Plasma-Lyte pH 7.4
5.6¡2.3
5.2¡1.4
5.7¡2.0
2.7¡0.7
3.2¡0.6
2.5¡0.4
4.7¡1.7
5.1¡0.7
3.8¡0.7
,0.0001*
0.221#
PWP Normal Saline
Lactated Ringer’s Solution
Plasma-Lyte pH 7.4
10.0¡3.5
12.8¡6.6
9.6¡3.0
6.7¡2.5
9.5¡3.7
7.8¡2.2
7.3¡2.5
10.4¡4.3
8.8¡1.7
0.620*
0.092#
SvO2 Normal Saline
Lactated Ringer’s Solution
Plasma-Lyte pH 7.4
70.5¡7.2
70.3¡5.5
74.5¡6.3
37.9¡6.2
46.3¡3.4
44.9¡12.6
53.8¡7.5
46.2¡17.0
57.1¡11.7
,0.0001*
0.283#
DO2 Normal Saline
Lactated Ringer’s Solution
Plasma-Lyte pH 7.4
541.6¡164.3
470.2¡100.8
604.6¡233.9
253.6¡39.2
283.1¡34.3
244.9¡67.0
360.8¡136.4
328.6¡55.4
321.8¡73.9
,0.0001*
0.762#
VO2 Normal Saline
Lactated Ringer’s Solution
Plasma-Lyte pH 7.4
142.5 + 82.4
119.3 + 12.3
120.9 + 24.9
142.7 + 26.0
136.3 + 19.4
129.7 + 47.8
145.9 + 41.2
140.8 + 23.9
163.4 + 97.9
0.471*
0.827#
Data are expressed as the mean ¡ SD.
{Equilibrium refers to the post-resuscitation phase, after 60 min of observation.
{{MAP, mean arterial pressure; HR, heart rate; CO, cardiac output; PWP, pulmonary wedge pressure; SvO2, mixed-venous oxygen saturation; DO2, oxygen
delivery; VO2, oxygen consumption.
*Two-way ANOVA for the factor Time (compared to BL, Hemorrhage, Equilibrium).
# Two-way ANOVA for the factor Group (no statistical significance was found for the Time6Group interaction).
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solution have the same general acid-base effect (SBE). This
result is consistent with previous studies in renal trans-
plantation patients, except when larger volumes were
infused, such as in the pump prime during cardiopulmon-
ary bypass.18 Importantly, Plasma-Lyte pH 7.4 did not cause
an accumulation of unmeasured anions as evidenced by the
sustained SIG values. Some concerns exist regarding the use
of LR, especially due to its low osmolarity (255–273 mOsm/
L). Some authors suggest that its use should be limited and
should be avoided for cases at risk of intracranial
hypertension.29 In addition, the induction or maintenance
of hyperlactemia by LR solution (as suggested by our
results) may be significant when larger volumes are infused.
Our study suggests that Plasma-Lyte pH 7.4 is a safe
alternative for the treatment of hemorrhagic shock.
Perhaps the most important point of our study is the use
of the metabolic acidosis magnitude as a clinical monitoring
tool. According to our results, resuscitation with normal
saline can disrupt the relationship between base deficit and
hypovolemia (an increased base deficit during resuscita-
tion). The misdiagnosis of worsening acidosis as tissue
hypoperfusion can be a factor leading to the overhydration
of many patients after major surgical procedures and is
correlated with the length of the intensive care unit stay.16
Fluid overload has also been associated with a prolonged
time on mechanical ventilation30 and a lower survival rate31
in critically ill patients. Avoidance of normal saline,
whenever base deficit needs to be monitored, can prevent
some of these problems. A similar consideration can be
made with respect to LR solution and the serum lactate
levels; however, based on our results and the results of
others, this point seems to be less important.
Our study has some limitations. First, our model caused
only low-level metabolic acidosis in the majority of the
animals. We would probably need to prolong the hypoten-
sive period to achieve a more significant acidosis, but this
extension could lead to death before resuscitation. Because
the shock-induced acidosis was not fundamental to our
study, we do not believe its absence is a significant
limitation to the interpretation of the results. Second, we
could not a priori define the sample size needed to detect
potential differences because there have been no similar
Figure 1 - Standard base excess (SBE), lactate and chloride plasma concentrations in the three groups.
Table 4 - Effects of crystalloid infusion on the acid-base
parameters.
Parameter Group Hemorrhage Equilibrium{ p-value*
pH Normal Saline
Lactated Ringer’s
Solution
Plasma-Lyte pH 7.4
7.31¡0.07
7.32¡0.03
7.36¡0.10
7.31¡0.09
7.31¡0.13
7.43¡0.08
0.506
PaCO2 (mmHg) Normal Saline
Lactated Ringer’s
Solution
Plasma-Lyte pH 7.4
55¡12
50¡3
44¡10
51¡14
57¡18
40¡8
0.425
Bicarbonate
(mEq/L)
Normal Saline
Lactated Ringer’s
Solution
Plasma-Lyte pH 7.4
26.8¡3.2
25.0¡2.0
23.7¡1.1
24.6¡3.0
26.8¡2.3
26.0¡1.1
0.045
SBE (mEq/L) Normal Saline
Lactated Ringer’s
Solution
Plasma-Lyte pH 7.4
2.0¡3.1
0.3¡2.0
-0.8¡1.2
0.96¡2.97
2.11¡2.57
1.67¡1.05
0.042
SIDai (mEq/L) Normal Saline
Lactated Ringer’s
Solution
Plasma-Lyte pH 7.4
41.9¡3.4
40.7¡3.3
42.8¡2.2
38.6¡3.3
41.7¡2.2
43.6¡2.6
0.152
Sodium (mEq/
L)
Normal Saline
Lactated Ringer’s
Solution
Plasma-Lyte pH 7.4
135.5¡1.8
135.5¡2.7
136.1¡3.4
136.8¡1.9
134.4¡3.5
134.7¡3.5
0.388
Chloride (mEq/
L)
Normal Saline
Lactated Ringer’s
Solution
Plasma-Lyte pH 7.4
102¡3
103¡5
102¡2
107¡3
101¡ 3
98¡2
0.018
Lactate (mEq/L) Normal Saline
Lactated Ringer’s
Solution
Plasma-Lyte pH 7.4
3.0¡1.3
2.5¡1.2
2.8¡0.6
1.5¡0.5
2.7¡1.8
1.9¡0.4
0.213
SIG (mEq/L) Normal Saline
Lactated Ringer’s
Solution
Plasma-Lyte pH 7.4
-0.1¡2.7
1.0¡1.7
4.7¡1.9
2.7¡1.8
2.0¡2.4
7.4¡2.3
0.511
Data are expressed as the mean ¡ SD.
{Equilibrium refers to the post-resuscitation period, after 60 min of
observation.
*Two-way ANOVA for the time factor (Hemorrhage/Equilibrium)
interaction.
+p,0.05 for the group factor (Normal Saline, Lactated Ringer’s Solution
and Plasma-Lyte pH 7.4).
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studies that we could use to estimate the magnitudes of the
effects. Therefore, we cannot exclude the possibility that
Plasma-Lyte pH 7.4 causes a greater increase in the SBE than
LR solution. However, if this difference does exist, it is
probably of a clinically irrelevant magnitude.
In summary, the three crystalloid solutions were able to
reverse the hemorrhagic shock–induced hemodynamic
disturbances. While normal saline was associated with
hyperchloremic acidosis, LR and Plasma-Lyte pH 7.4 did
not result in hyperchloremic acidosis and led to a more
acceptable metabolic profile. Based on our results, Plasma-
Lyte pH 7.4 should be considered a reasonable alternative in
the treatment of hemorrhagic shock. However, future
clinical studies should address this specific point.
This is the first study that simultaneously compared the
effects of three different crystalloid solutions on acid-base
and hemodynamic profiles following hemorrhagic shock.
Although the three crystalloid solutions tested were equally
able to attenuate the hemodynamic and tissue perfusion
changes following induction of hemorrhagic shock, only
normal saline induced hyperchloremia and metabolic
acidosis.
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